OBJECTIVE: To investigate medical decision-making capacity (MDC) in patients with acute traumatic brain injury (TBI) across a range of injury severity. METHODS: We evaluated MDC cross-sectionally 1 month after injury in 40 healthy controls and 86 patients with TBI stratified by injury severity (28 mild [mTBI], 15 complicated mild [cmTBI], 43 moderate/severe [msevTBI]). We compared group performance on the Capacity to Consent to Treatment Instrument and its 5 consent standards (expressing choice, reasonable choice, appreciation, reasoning, understanding). Capacity impairment ratings (no impairment, mild/moderate impairment, severe impairment) on the consent standards were also assigned to each participant with TBI using cut scores referenced to control performance. RESULTS: One month after injury, the mTBI group performed equivalently to controls on all consent standards. In contrast, the cmTBI group was impaired relative to controls on the understanding standard. No differences emerged between the mTBI and cmTBI groups. The msevTBI group was impaired on almost all standards relative to both control and mTBI groups, and on the understanding standard relative to the cmTBI group. Capacity compromise (mild/moderate or severe impairment ratings) on the 3 clinically complex standards (understanding, reasoning, appreciation) occurred in 10%-30% of patients with mTBI, 50% of patients with cmTBI, and 50%-80% of patients with msevTBI. CONCLUSIONS: One month following injury, MDC is largely intact in patients with mTBI, but is impaired in patients with cmTBI and msevTBI. Impaired MDC is prevalent in acute TBI and is strongly related to injury severity.
OBJECTIVE: To investigate medical decision-making capacity (MDC) in patients with acute traumatic brain injury (TBI) across a range of injury severity. METHODS: We evaluated MDC cross-sectionally 1 month after injury in 40 healthy controls and 86 patients with TBI stratified by injury severity (28 mild [mTBI], 15 complicated mild [cmTBI], 43 moderate/severe [msevTBI]). We compared group performance on the Capacity to Consent to Treatment Instrument and its 5 consent standards (expressing choice, reasonable choice, appreciation, reasoning, understanding). Capacity impairment ratings (no impairment, mild/moderate impairment, severe impairment) on the consent standards were also assigned to each participant with TBI using cut scores referenced to control performance. RESULTS: One month after injury, the mTBI group performed equivalently to controls on all consent standards. In contrast, the cmTBI group was impaired relative to controls on the understanding standard. No differences emerged between the mTBI and cmTBI groups. The msevTBI group was impaired on almost all standards relative to both control and mTBI groups, and on the understanding standard relative to the cmTBI group. Capacity compromise (mild/moderate or severe impairment ratings) on the 3 clinically complex standards (understanding, reasoning, appreciation) occurred in 10%-30% of patients with mTBI, 50% of patients with cmTBI, and 50%-80% of patients with msevTBI. CONCLUSIONS: One month following injury, MDC is largely intact in patients with mTBI, but is impaired in patients with cmTBI and msevTBI. Impaired MDC is prevalent in acute TBI and is strongly related to injury severity.
Authors: Daniel C Marson; Laura E Dreer; Sara Krzywanski; Justin S Huthwaite; Michael J Devivo; Thomas A Novack Journal: Arch Phys Med Rehabil Date: 2005-05 Impact factor: 3.966
Authors: O Okonkwo; H R Griffith; K Belue; S Lanza; E Y Zamrini; L E Harrell; J C Brockington; D Clark; R Raman; D C Marson Journal: Neurology Date: 2007-10-09 Impact factor: 9.910
Authors: Michael McCrea; Kevin M Guskiewicz; Stephen W Marshall; William Barr; Christopher Randolph; Robert C Cantu; James A Onate; Jingzhen Yang; James P Kelly Journal: JAMA Date: 2003-11-19 Impact factor: 56.272
Authors: Kristen L Triebel; Roy C Martin; Thomas A Novack; Laura E Dreer; Crystal Turner; Richard Kennedy; Daniel C Marson Journal: Arch Phys Med Rehabil Date: 2014-08-22 Impact factor: 3.966
Authors: Kristen L Triebel; Thomas A Novack; Richard Kennedy; Roy C Martin; Laura E Dreer; Rema Raman; Daniel C Marson Journal: J Head Trauma Rehabil Date: 2016 May-Jun Impact factor: 2.710
Authors: Kayla A Steward; Richard Kennedy; Thomas A Novack; Michael Crowe; Daniel C Marson; Kristen L Triebel Journal: J Head Trauma Rehabil Date: 2018 Jan/Feb Impact factor: 2.710
Authors: Kristen L Triebel; Adam Gerstenecker; Karen Meneses; John B Fiveash; Christina A Meyers; Gary Cutter; Daniel C Marson; Roy C Martin; Amanda Eakin; Olivia Watts; Louis B Nabors Journal: Psychooncology Date: 2015-01-23 Impact factor: 3.894
Authors: Timothy E Ham; Valerie Bonnelle; Peter Hellyer; Sagar Jilka; Ian H Robertson; Robert Leech; David J Sharp Journal: Brain Date: 2013-12-26 Impact factor: 13.501
Authors: Kayla A Steward; Adam Gerstenecker; Kristen L Triebel; Richard Kennedy; Thomas A Novack; Laura E Dreer; Daniel C Marson Journal: Neurology Date: 2016-08-10 Impact factor: 9.910